Literature DB >> 3485669

Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82.

K L Gould, R A Goldstein, N A Mullani, R L Kirkeeide, W H Wong, T J Tewson, M S Berridge, L A Bolomey, R K Hartz, R W Smalling.   

Abstract

The purpose of this study was to determine the clinical feasibility of diagnosing significant coronary artery disease by positron imaging of myocardial perfusion without a cyclotron, using generator-produced rubidium-82 (82Rb). Fifty patients underwent positron emission tomography of the entire heart using a multislice positron camera and intravenous 82Rb or nitrogen-13 ammonia (13NH3) before and after intravenous dipyridamole combined with handgrip stress. Images were read by two observers blinded as to clinical or arteriographic data. Automated quantitative coronary arteriography was obtained for the arteriographic determination of coronary flow reserve, previously demonstrated to be a single integrated measure of stenosis severity accounting for all its geometric dimensions of length, absolute diameter, percent narrowing and asymmetry by quantitative analysis of cine films. Significant coronary artery disease was defined as an arteriographically determined coronary flow reserve of less than 3.0 based on all stenosis dimensions. Any single geometric measure of stenosis severity alone was an inadequate reference standard for comparison with perfusion images. Sensitivity of identifying patients with coronary artery disease having an arteriographically determined coronary flow reserve of less than 3.0 was 95% by positron imaging with a specificity of 100%. The single case that was missed, studied with 13NH3, had a 43% diameter narrowing of a small ramus intermedius off the left coronary artery with no significant narrowing of the major coronary arteries. Positron emission tomography of myocardial perfusion before and after intravenous dipyridamole combined with handgrip stress utilizing generator-produced 82Rb provides sensitive and specific diagnosis of reduced coronary flow reserve due to coronary artery disease in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485669     DOI: 10.1016/s0735-1097(86)80336-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  Estimation of coronary flow reserve: can SPECT compete with other modalities?

Authors:  G T Gullberg; E V Di Bella; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

2.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Assessment of coronary flow reserve and microcirculation: a clinical perspective.

Authors:  Roxana Campisi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

Review 4.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

5.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Authors:  Rob S B Beanlands; George Youssef
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

6.  Assessing progression or regression of CAD: the role of perfusion imaging.

Authors:  K Lance Gould
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

7.  82-Rubidium--the dawn of cardiac PET in Europe?

Authors:  Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12       Impact factor: 9.236

8.  Cardiac 82Rubidium PET/CT: initial European experience.

Authors:  Ashley M Groves; Marie-Elsya Speechly-Dick; John C Dickson; Irfan Kayani; Raymondo Endozo; Patty Blanchard; Manu Shastry; Elizabeth Prvulovich; Wendy A Waddington; Simona Ben-Haim; Jamshed B Bomanji; Jean R McEwan; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-31       Impact factor: 9.236

9.  High-resolution visualization of mouse cardiac microvasculature using optical histology.

Authors:  Austin J Moy; Patrick C Lo; Bernard Choi
Journal:  Biomed Opt Express       Date:  2013-12-04       Impact factor: 3.732

Review 10.  Clinical cardiac PET using generator-produced Rb-82: a review.

Authors:  K L Gould
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Sep-Oct       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.